On June 25th, 2018, Glaukos Corporation announced it received premarket approval (PMA) from the FDA for the iStent inject® Trabecular Micro-Bypass System.  The iStent inject® is indicated for the reduction of intraocular pressure (IOP) in adult mild-to-moderate primary open-angle glaucoma (POAG) patients who are also undergoing cataract surgery. In order to achieve their goal of transforming the… Read More

In 2014 after she had her cataract surgery, Diana’s doctor noticed a rise in her IOP (intraocular pressures). A year later, because of her IOP, she was referred to see Dr. Cruz Colon, a glaucoma sub-specialist at our office who specializes in patients with severe glaucoma. Like many patients with severe glaucoma, Diana was prescribed 3 different… Read More